NASDAQ: CRNX - Crinetics Pharmaceuticals, Inc.

Price = Avg Price + (Avg Price * CAGR EPS% / 100)
EPS = Earning Per Share
CAGR EPS = CAGR 5 EPS
Key Rate — Nøkkelrente
Excess Key Rate — Ønsket overskridelse av styringsrenten
EPS = -3.69
CAGR EPS = 12.07%
Key Rate = 0.0433
Excess Key Rate = 2
Price = 37.27 + (37.27 * 12.07% / 100) = 41.76

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Discount Ebitda / (1 + WACC) ^ 5)
Discount Ebitda(5) = -0.7593
Ebitda Yield = 0.2794
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.0043
Debt = 0.0517
Market Cap = 0.8826
Weight Debt = Market Cap / (Market Cap + Debt) = 0.8826 / (0.8826 + 0.0517) = 0.9446
Weight Cost Debt = 100% - 0.9446 = 0.0554
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 3
β = -2.8
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 3 + -2.8 * 5.94 + 0 = -0.1365
WACC = (0.0043 / 0.0517) * (100% - 0.9446) * (1 - 0.21) + -0.1365 + 0.9446 = 6.38
Terminal Value = Discount (-0.7593 * (1 + 0.2794) / (6.38 - 0.2794)) = -3.31
Company Value = ∑ (-0.7593 / (1 + 6.38) ^ 5) = -1.99
Price = (Terminal Value + Company Value) / Count shares = (-3.31 + -1.99) / 58070000 = -91.28

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield)
Company Value = ∑ (Discount FCF / (1 + WACC) ^ 5)
Discount FCF(5) = -0.4928
FCF Yield = 0.2358
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.0043
Debt = 0.0517
Market Cap = 0.8826
Weight Debt = Market Cap / (Market Cap + Debt) = 0.8826 / (0.8826 + 0.0517) = 0.9446
Weight Cost Debt = 100% - 0.9446 = 0.0554
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 3
β = -2.8
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 3 + -2.8 * 5.94 + 0 = -0.1365
WACC = (0.0043 / 0.0517) * (100% - 0.9446) * (1 - 0.21) + -0.1365 + 0.9446 = 6.38
Terminal Value = Discount (-0.4928 * (1 + 0.2358) / (6.38 - 0.2358)) = -2.6
Company Value = ∑ (-0.4928 / (1 + 6.38) ^ 5) = -1.37
Price = (Terminal Value + Company Value) / Count shares = (-2.6 + -1.37) / 58070000 = -68.36